Traws Pharma (TRAW) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $7.9 million.
- Traws Pharma's Total Current Liabilities fell 552.23% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 552.23%. This contributed to the annual value of $11.5 million for FY2024, which is 2508.68% up from last year.
- According to the latest figures from Q3 2025, Traws Pharma's Total Current Liabilities is $7.9 million, which was down 552.23% from $7.4 million recorded in Q2 2025.
- Traws Pharma's Total Current Liabilities' 5-year high stood at $11.5 million during Q4 2024, with a 5-year trough of $5.9 million in Q1 2022.
- Its 5-year average for Total Current Liabilities is $8.3 million, with a median of $8.0 million in 2022.
- Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 3897.81% in 2021, then soared by 5507.73% in 2023.
- Traws Pharma's Total Current Liabilities (Quarter) stood at $6.1 million in 2021, then surged by 31.58% to $8.0 million in 2022, then grew by 14.59% to $9.2 million in 2023, then rose by 25.09% to $11.5 million in 2024, then tumbled by 31.61% to $7.9 million in 2025.
- Its Total Current Liabilities was $7.9 million in Q3 2025, compared to $7.4 million in Q2 2025 and $10.4 million in Q1 2025.